Fibrinogen is associated with EGFR mutation status and lymphatic metastasis in non-small cell lung cancer

In the previous decade, tyrosine kinase inhibitors (TKIs) have demonstrated significant effects in patients with non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations. However, sufficient tumor tissue for genetic testing cannot always be obtained in clinical setti...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncol Lett
Egile Nagusiak: Guan, Jian, Xiao, Nan, Qiu, Chun, Li, Qin, Chen, Min, Zhang, Yao, Dai, Yong, Li, Lu, Zhang, Yue, Yang, Mi, Chen, Long, Liu, Lai Yu
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: D.A. Spandidos 2019
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6312965/
https://ncbi.nlm.nih.gov/pubmed/30655825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.9652
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak